EP2240470A4 - Improved and novel process for the preparation of bosentan - Google Patents

Improved and novel process for the preparation of bosentan

Info

Publication number
EP2240470A4
EP2240470A4 EP09705099A EP09705099A EP2240470A4 EP 2240470 A4 EP2240470 A4 EP 2240470A4 EP 09705099 A EP09705099 A EP 09705099A EP 09705099 A EP09705099 A EP 09705099A EP 2240470 A4 EP2240470 A4 EP 2240470A4
Authority
EP
European Patent Office
Prior art keywords
bosentan
preparation
improved
novel process
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09705099A
Other languages
German (de)
French (fr)
Other versions
EP2240470A2 (en
Inventor
Reddy Manne Satyanarayana
Sajja Eswaraiah
Reddy Ghojala Venkat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSN Laboratories Pvt Ltd
Original Assignee
MSN Laboratories Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MSN Laboratories Pvt Ltd filed Critical MSN Laboratories Pvt Ltd
Publication of EP2240470A2 publication Critical patent/EP2240470A2/en
Publication of EP2240470A4 publication Critical patent/EP2240470A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
EP09705099A 2008-01-10 2009-01-09 Improved and novel process for the preparation of bosentan Withdrawn EP2240470A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN103CH2008 2008-01-10
IN2334CH2008 2008-09-24
PCT/IN2009/000032 WO2009095933A2 (en) 2008-01-10 2009-01-09 Improved and novel process for the preparation of bosentan

Publications (2)

Publication Number Publication Date
EP2240470A2 EP2240470A2 (en) 2010-10-20
EP2240470A4 true EP2240470A4 (en) 2012-05-23

Family

ID=40913375

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09705099A Withdrawn EP2240470A4 (en) 2008-01-10 2009-01-09 Improved and novel process for the preparation of bosentan

Country Status (2)

Country Link
EP (1) EP2240470A4 (en)
WO (1) WO2009095933A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2222649A2 (en) 2007-10-24 2010-09-01 Generics (UK) Limited Novel crystalline forms
EP2240469A2 (en) * 2008-01-24 2010-10-20 Actavis Group PTC EHF Substantially pure and a stable crystalline form of bosentan
NZ587793A (en) 2008-02-08 2012-06-29 Generics Uk Ltd Process for preparing bosentan
WO2010015623A1 (en) * 2008-08-05 2010-02-11 Farmaprojects, S. A. Process for the preparation of endothelin receptor antagonists
WO2010032261A1 (en) * 2008-08-12 2010-03-25 Cadila Healthcare Limited Process for preparation of bosentan
CN102272108A (en) * 2008-11-03 2011-12-07 基因里克斯(英国)有限公司 Hplc method for the analysis of bosentan and related substances and use of these substances as reference standards and markers
IT1393136B1 (en) 2009-03-11 2012-04-11 Sifa Vitor S R L PROCEDURE FOR THE PREPARATION OF BOSENTAN
RU2011145813A (en) 2009-04-13 2013-05-20 Сандох Аг METHOD FOR OBTAINING AN ENDOTHELIAL RECEPTOR ANTAGONIST (BOSENTAN)
WO2011021216A2 (en) * 2009-08-10 2011-02-24 Msn Laboratories Limited Improved process for the preparation of 4-(1,1-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide
WO2011024056A2 (en) 2009-08-27 2011-03-03 Aurobindo Pharma Limited An improved process for the preparation of bosentan
CA2781541A1 (en) * 2009-11-12 2011-05-19 Ranbaxy Laboratories Limited Crystalline forms of bosentan salt and processes for their preparation
US9139537B2 (en) 2010-08-11 2015-09-22 Megafine Pharma(P) Ltd. Process for preparation of bosentan
SI2621909T1 (en) * 2010-10-01 2019-04-30 Zach System S.P.A. Process for preparing bosentan monohydrate and its intermediates
US20130245259A1 (en) 2012-03-16 2013-09-19 Natco Pharma Limited Process for the preparation of bosentan monohydrate
WO2013186706A1 (en) * 2012-06-12 2013-12-19 Cadila Pharmaceuticals Ltd Process for the preparation of bosentan
TR202018841A2 (en) * 2020-11-23 2021-01-21 Yilmaz Usta Duygu FORMULATION OF BOSENTAN MONOHYDRATE LOADED SELF-NANOEMULSIFIED DRUG CARRIER SYSTEMS (SNEDDS) PREPARED WITH LONG-CHAIN MONO AND DIGLYCERIDE MIXTURES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292740A (en) * 1991-06-13 1994-03-08 Hoffmann-La Roche Inc. Sulfonamides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW287160B (en) * 1992-12-10 1996-10-01 Hoffmann La Roche
AU2001263850A1 (en) * 2000-04-20 2001-11-07 Actelion Pharmaceuticals Ltd Pyrimidine-sulfonamides having endothelin-antagonist activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292740A (en) * 1991-06-13 1994-03-08 Hoffmann-La Roche Inc. Sulfonamides

Also Published As

Publication number Publication date
WO2009095933A2 (en) 2009-08-06
EP2240470A2 (en) 2010-10-20
WO2009095933A3 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
EP2240470A4 (en) Improved and novel process for the preparation of bosentan
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
ZA201202504B (en) Process for the preparation of calcobutrol
PL2151428T3 (en) Process for the preparation of agomelatin
SI2387566T1 (en) Process for the preparation of rosuvastatin
ZA200907191B (en) Process for the preparation of gefitiib
IL208792A0 (en) Process for the preparation of amides
HK1169396A1 (en) Improved process for the preparation of ambrisentan and novel intermediates thereof
PL390042A1 (en) Process for the preparation of kvass
SI2189442T1 (en) Process and intermediates for the preparation of aliskiren
EP2300467A4 (en) Novel and improved processes for the preparation of paliperidone
PT2151429E (en) Process for the preparation of agomelatin
IL243809A0 (en) Process for the procuction of γ-ketosulfide compounds and γ-ketosulfide compounds
EG26332A (en) Process for the preparation of benzonorbornenes
PL388931A1 (en) Process for the preparation of fluorocarbfunctional silesquioxanes
HU0700818D0 (en) Process for the preparation of polyirocyanates of the diphenylmethone series
IL208868A0 (en) Processes for the preparation of amides
IL211382A0 (en) Process for the preparation of ethanedinitrile
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
PL2462154T3 (en) Novel crystal form of cdb-4124 and process for the preparation thereof
IL213110A0 (en) Process for the preparation of tetrazine derivatives
GB0812613D0 (en) Process for the preparation of 1-deoxyidonojirimycin
EG27000A (en) Process for the preparation of ibodutant (MEN15596) and related intermediates
IL220160A (en) Process for the preparation of defferasirox
PL388933A1 (en) Process for the preparation of fluorosilicones

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100810

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 401/04 20060101AFI20110706BHEP

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

A4 Supplementary search report drawn up and despatched

Effective date: 20120420

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 239/52 20060101ALI20120416BHEP

Ipc: C07D 239/47 20060101AFI20120416BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121120